Transforming Oncology through Artificial Intelligence / CNIO CaixaResearch Frontiers Meeting

This meeting will explore the transformative impact of artificial intelligence (AI) and machine learning (ML) on cancer research, diagnostics, and treatment. Bringing together world-leading scientists, clinicians, and AI innovators, this meeting will highlight the latest advances in computational oncology—from large-scale data integration and imaging analysis to AI-driven drug discovery and clinical decision support. With a focus on interdisciplinary collaboration and translational impact, the meeting aims to foster dialogue and spark innovation at the intersection of cancer biology and data science.

Speakers
Dr. Hana Aliee, CRUK Cambridge Institute, University of Cambridge, UK
Dr. Patrick Aloy, Institute for Research in Biomedicine (IRB), Spain
Dr. Leonor Cerdá-Alberich, La Fe Health Research Institute, Spain
Dr. Edwin Cuppen, Hartwig Medical Foundation; UMC Utrecht, The Netherlands
Dr. James DeGregori, University of Colorado Anschutz, US
Dr. Miquel Duran Frigola, Ersilia Open Source Initiative, Spain
Dr. Noelia Ferruz, Centre for Genomic Regulation (CRG), Spain
Dr. Faisal Mahmood, Brigham and Women's Hospital, Harvard Medical School, US
Dr. Aidan Meade, Technological University Dublin, Ireland
Dr. Chirag J. Patel, Blavatnik Institute, Harvard Medical School, US
Dr. María Rodriguez, Yale School of Medicine, US
Dr. Julio Sáez-Rodríguez, European Bioinformatics Institute (EMBL-EBI), UK
Dr. Giovanni Tonon, Centre for Omics Sciences; Vita-Salute San Raffaele University, Italy
Dr. Alfonso Valencia, Barcelona Supercomputing Center (BSC), Spain
Dr. Bo Wang, Vector Institute, Canada
Dr. Haiyuan Yu, Tisch University, US